Profil
Amer Alghabban worked as a Director at Merck KGaA, a Managing Director at Gxp Compliance & Training Partners, a Senior Audit Manager at Novartis AG, a Global Head-GxP Quality Assurance at Arpida AG, a VP-GxP, Quality Assurance, Compliance & Training at Karyopharm Therapeutics, Inc., and a Compliance Officer at Medicines & Healthcare Products Regulatory Agency.
Anciens postes connus de Amer Alghabban
| Sociétés | Poste | Fin |
|---|---|---|
Medicines & Healthcare Products Regulatory Agency
Medicines & Healthcare Products Regulatory Agency General GovernmentGovernment Regulates medicines, medical devices and equipment of healthcare to safeguard the public health | Compliance Officer | - |
| NOVARTIS AG | Comptroller/Controller/Auditor | - |
Arpida AG
Arpida AG BiotechnologyHealth Technology Develops and manufactures novel drugs | Corporate Officer/Principal | - |
| MERCK KGAA | Directeur/Membre du Conseil | - |
Gxp Compliance &Training Partners | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Arpida AG
Arpida AG BiotechnologyHealth Technology Develops and manufactures novel drugs | Health Technology |
Karyopharm Therapeutics, Inc.
Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Medicines & Healthcare Products Regulatory Agency
Medicines & Healthcare Products Regulatory Agency General GovernmentGovernment Regulates medicines, medical devices and equipment of healthcare to safeguard the public health | Government |
Gxp Compliance &Training Partners |
















